M olecular imaging is a rapidly evolving field that allows us to investigate the activity of specific physiological and pathological processes in vivo. However, this approach will only be as good as the imaging tracers that can be developed, and at present these are somewhat limited, at least for cardiovascular imaging. Ideally, novel tracers should not only be specific for a disease process of biological interest but also should inform about its activity in a safe, high-resolution, and nonobtrusive manner. The description by , in this issue of iJACC, outlining the effective labeling of the high-density lipoprotein (HDL) particle with a positron-emitting radiotracer is therefore of major interest, providing us with a new tool with which to study the biological features of reverse cholesterol transport and to identify high-risk atheroma. In fact, the authors (1) have already labeled the HDL particle using magnetic resonance (MR)-based contrast agents (2). However positron emission tomography (PET) offers major advantages principally related to its exquisite sensitivity, which allows detection of even nanomolar concentrations of a radiotracer. The tracking of labeled particles at concentrations low enough not to influence the underlying disease process has therefore become feasible.
least for cardiovascular imaging. Ideally, novel tracers should not only be specific for a disease process of biological interest but also should inform about its activity in a safe, high-resolution, and nonobtrusive manner. The description by Pérez-Medina et al. (1) , in this issue of iJACC, outlining the effective labeling of the high-density lipoprotein (HDL) particle with a positron-emitting radiotracer is therefore of major interest, providing us with a new tool with which to study the biological features of reverse cholesterol transport and to identify high-risk atheroma. In fact, the authors (1) have already labeled the HDL particle using magnetic resonance (MR)-based contrast agents (2) . However positron emission tomography (PET) offers major advantages principally related to its exquisite sensitivity, which allows detection of even nanomolar concentrations of a radiotracer. The tracking of labeled particles at concentrations low enough not to influence the underlying disease process has therefore become feasible.
Although the objective of this paper is in many ways simple-to label and track the HDL particle using PET-the methodology used is both innovative and comprehensive. In-depth investigation of the behavior and biodistribution of the zirconium-89 Kingdom. E-mail: d.e.newby@ed.ac.uk.
